Obsidian Therapeutics, Inc. (OBX)
Last updated: 2026-10-21 16:14:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Obsidian Therapeutics, Inc. (OBX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $14.00, with a market capitalization of $737.57M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.52 to $49.97. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$737.57M | |
$13.34 | |
$49.97 | |
$11.52 | |
$13.25 | |
113.58K | |
402.74K | |
-- | |
$49.97 | |
$11.52 | |
-- | |
-- |
Obsidian Therapeutics, Inc. (OBX) Stock Price Today
Obsidian Therapeutics, Inc. (OBX) is currently trading at $14.00 as of 2026-10-21 15:58:32, up 5.66% ($0.75) from the previous close of $13.25
During today's regular trading session, OBX has traded between $11.52 and $49.97, with a trading volume of 113.58K shares. The current price is near the lower end of today's range.
Obsidian Therapeutics, Inc. (OBX) 7-Day Stock Price Change
Over the past seven days, Obsidian Therapeutics, Inc. (OBX) moved from $12.79 to $14.00, representing a gain of 9.46% ($1.21).
The stock traded between $11.52 and $14.58 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 307.28 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
OBX 52-Week Price Position
Position in Range: 6.4%
OBX is currently trading at $14.00, placing it 6.4% of the way from its 52-week low of $11.52 to its 52-week high of $49.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Obsidian Therapeutics, Inc. (OBX)?
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
Obsidian Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
How to Buy Obsidian Therapeutics, Inc. (OBX) Stock on MEXC
Eligible investors can buy real shares of Obsidian Therapeutics, Inc. (OBX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Obsidian Therapeutics, Inc. (OBX) stock price today?
2.Is OBX stock going up or down today?
3.What is OBX pre-market price?
4.What is OBX after-hours price?
5.Is OBX stock trading now?
6.Where does OBX sit relative to its 52-week high and low?
7.What sector is Obsidian Therapeutics, Inc. in?
8.What is Obsidian Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is OBX valued in terms of P/E ratio and EPS?
10.Does Obsidian Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
OBX Stock Calculator
Estimate the value between OBX shares and USD.
OBX Shares to USD
1.00 OBX shares = 14 USD
Calculations are estimates based on the latest available price and are for reference only.


